Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

Objectives: Ceftolozane/tazobactam (C–T) is an antimicrobial combination of an antipseudomonal cephalosporin and a β-lactamase inhibitor. C–T has been approved in >60 countries for complicated urinary tract infections, acute pyelonephritis, complicated intra-abdominal infections in combination wi...

Full description

Bibliographic Details
Main Authors: Dee Shortridge, Michael A. Pfaller, Jennifer M. Streit, Robert K. Flamm
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716519302632